
Tandem Diabetes Care TNDM
$ 22.56
-0.27%
Quarterly report 2025-Q3
added 11-06-2025
Tandem Diabetes Care Cash Conversion Cycle 2011-2025 | TNDM
Annual Cash Conversion Cycle Tandem Diabetes Care
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 228 | 283 | 96.4 | 98.4 | 106 | 115 | 121 | 196 | 131 | 168 | 162 | 194 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 283 | 96.4 | 158 |
Quarterly Cash Conversion Cycle Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 | 115 | 120 | - | 122 | 131 | 148 | - | 138 | 125 | 125 | - | 44.9 | 37.5 | 93.6 | 43.1 | 85.5 | 85.3 | 107 | 44.6 | 133 | 145 | 134 | 39.2 | 110 | 84.2 | 81.7 | 42.1 | 118 | 157 | 194 | 47.1 | 202 | 239 | 209 | 35.3 | 173 | 129 | 148 | 44 | 192 | 185 | 187 | 39 | 151 | 202 | 187 | 47.2 | 201 | 230 | 151 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 239 | 35.3 | 123 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Boston Scientific Corporation
BSX
|
118 | $ 95.66 | -0.45 % | $ 141 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
156 | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
Apyx Medical Corporation
APYX
|
246 | $ 3.57 | -0.96 % | $ 124 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
263 | $ 301.17 | 0.05 % | $ 8.5 B | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
IRIDEX Corporation
IRIX
|
119 | $ 1.12 | 1.7 % | $ 18.1 M | ||
|
Bruker Corporation
BRKR
|
227 | $ 47.9 | -0.25 % | $ 7.14 K | ||
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
100 | $ 125.02 | 0.39 % | $ 218 B | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
129 | $ 63.52 | 0.43 % | $ 3.45 B | ||
|
LENSAR
LNSR
|
147 | $ 12.05 | 0.21 % | $ 139 M | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 2.9 | 2.11 % | $ 108 M | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 9.57 | 0.31 % | $ 687 M | ||
|
Quanterix Corporation
QTRX
|
173 | $ 6.54 | -1.51 % | $ 246 M | ||
|
InMode Ltd.
INMD
|
180 | $ 14.48 | 0.77 % | $ 1.15 B | ||
|
IRadimed Corporation
IRMD
|
267 | $ 97.3 | 0.72 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
137 | $ 157.11 | 0.22 % | $ 11.8 B | ||
|
Accuray Incorporated
ARAY
|
184 | $ 0.86 | 0.21 % | $ 88.4 M | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
240 | $ 14.5 | 0.87 % | $ 392 M | ||
|
FONAR Corporation
FONR
|
234 | $ 14.48 | -0.28 % | $ 94.9 M | ||
|
AxoGen
AXGN
|
195 | $ 32.91 | 0.2 % | $ 1.46 B | ||
|
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
218 | $ 40.08 | 1.11 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
723 | $ 17.4 | 0.67 % | $ 402 M | ||
|
Globus Medical
GMED
|
319 | $ 88.59 | -0.2 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 12.68 | 0.68 % | $ 976 M | ||
|
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | ||
|
Aethlon Medical
AEMD
|
-61.8 | $ 2.64 | -0.75 % | $ 4.12 M |